Skip to main content

Advertisement

SpringerLink
Log in

Author’s response to the Letter to the Editor of Tfelt-Hansen

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Macedo A, Farré M, Baños J-E (2006) A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some characteristics of clinical trials. Eur J Clin Pharmacol 62:161–172

    Article  PubMed  Google Scholar 

  2. Committee for Medicinal Products for Human Use (CHMP) (2007) Guideline on clinical investigation of medicinal products for the treatment of migraine. Doc. Ref. CPMP/EWP/788/01 Rev. 1. European Medicines Agency, London

  3. Tfelt-Hansen P, Block G, Dahlöf C, Diener HC, Ferrari MD, Goadsby PJ, Guidetti V, Jones B, Lipton RB, Massiou H, Meinert C, Sandrini G, Steiner T, Winter PB, International Headache Society Clinical Trials Subcommittee (2000) Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 20:765–786

    Article  PubMed  CAS  Google Scholar 

  4. Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winer PK (2008) Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet 372:2115–2123

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Bellaterra, Spain

    Ana Macedo & Magí Farré

  2. Human Pharmacology and Neurosciences, IMIM–Institut de Recerca Hospital del Mar, Parc de Salut Mar, Barcelona, Spain

    Magí Farré

  3. Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Dr. Aiguader 88, 08003, Barcelona, Spain

    Josep-E. Baños

Authors
  1. Ana Macedo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Magí Farré
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Josep-E. Baños
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Josep-E. Baños.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Macedo, A., Farré, M. & Baños, JE. Author’s response to the Letter to the Editor of Tfelt-Hansen. Eur J Clin Pharmacol 67, 645–646 (2011). https://doi.org/10.1007/s00228-010-0954-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-010-0954-7

Keywords

Search

Navigation